177 related articles for article (PubMed ID: 6424474)
1. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Roy S; Mishell DR; Robertson DN; Krauss RM; Lacarra M; Duda MJ
Am J Obstet Gynecol; 1984 Apr; 148(7):1006-13. PubMed ID: 6424474
[TBL] [Abstract][Full Text] [Related]
2. First year clinical experience with six levonorgestrel rods as subdermal contraception.
Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
[TBL] [Abstract][Full Text] [Related]
3. Norplant contraceptive implants: rods versus capsules.
Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
[TBL] [Abstract][Full Text] [Related]
4. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
[TBL] [Abstract][Full Text] [Related]
5. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
[TBL] [Abstract][Full Text] [Related]
6. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
Robertson DN; Sivin I; Nash HA; Braun J; Dinh J
Contraception; 1983 May; 27(5):483-95. PubMed ID: 6411428
[TBL] [Abstract][Full Text] [Related]
7. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
Diaz S; Pavez M; Miranda P; Robertson DN; Sivin I; Croxatto HB
Contraception; 1982 May; 25(5):447-56. PubMed ID: 6809423
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
[TBL] [Abstract][Full Text] [Related]
9. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
10. A new delivery system for contraceptive steroids.
Segal S
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
Thomsen RJ; Pasquale S; Nosher J
Int J Gynaecol Obstet; 1985 Jun; 23(3):223-7. PubMed ID: 2865186
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
13. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
14. Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
Hingorani V; Jalnawala SF; Kochhar M; Rai Chaudhury G; Sengupta PC; Datey S; Mehta S; Roy M; Saxena NC; Saxena BN
Contraception; 1986 Mar; 33(3):233-44. PubMed ID: 3087694
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
16. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
17. Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women.
Lithell H; Weiner E; Vessby B; Johansson ED
Ups J Med Sci; 1983; 88(2):103-8. PubMed ID: 6417867
[TBL] [Abstract][Full Text] [Related]
18. Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.
Robertson DN; Diaz S; Alvarez-Sanchez F; Holma P; Mishell DR; Coutinho E; Brache V; Croxatto HB; Faundes A; Lacarra M
Contraception; 1985 Apr; 31(4):351-9. PubMed ID: 3924476
[TBL] [Abstract][Full Text] [Related]
19. Norplant: subdermal implant system for long-term contraception.
Shoupe D; Mishell DR
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
[TBL] [Abstract][Full Text] [Related]
20. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
